23 May 2013
Keywords: taro, generic, levetiracetam, cleared, fda, subsidiary, israel
Article | 16 February 2009
The US subsidiary of Israel's Taro Pharmaceutical has received approval from the Food and Drug Administration for its Abbreviated New ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2009
22 May 2013
© 2013 thepharmaletter.com